A New HIV Vaccine Could Be One of Moderna's Next MRNA Success Story
Photo by CHANDAN KHANNA/AFP via Getty Images Moderna's mRNA tech could change the game in the decades-long effort to develop an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021. While "excited" by the prospect, HIV researchers caution there's a long road ahead for mRNA vaccines. Moderna's investor presentation on Wednesday showcased the Massachusetts-based biotech's efforts to develop vaccines against HIV and eight other infectious diseases. The company's mRNA technology, which has built upon decades of research, w...